Form 4: BioCardia CEO Peter Altman Acquires Additional Shares
SEC Form 4
BioCardia's President and CEO, Peter Altman, recently purchased 500 shares of the company's common stock at an average price of $1.96 per share.
Summary
- On April 7, 2025, Peter Altman, the President and CEO of BioCardia, Inc., acquired 500 shares of common stock.
- The shares were purchased at a price of $1.96 per share.
- Following this transaction, Altman directly owns 112,020 shares of BioCardia's common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports a transaction. It doesn't indicate positive or negative outlook for the company.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor management's confidence in the company's stock.
Stakeholder Impact
- The purchase could be viewed positively by shareholders as it signals confidence from the CEO.
Key Dates
| Date | Description |
|---|---|
| 04/07/2025 | Date of transaction: Peter Altman purchased 500 shares of BCDA. |
| 04/08/2025 | Date of signature on the Form 4 filing. |
Keywords
BioCardia, BCDA, Peter Altman, Insider Trading, Form 4, Stock Acquisition, Executive Purchase
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.